Switch to:
More From Other Websites
Sarepta Therapeutics (SRPT) Stock Falls on Q2 Earnings Loss Jul 20 2016
Sarepta (SRPT) Posts Y/Y Wider Q2 Loss, Eteplirsen in Focus Jul 20 2016
Morning Movers: Morgan Stanley Jumps on Earnings; Valeant Pharmaceuticals Climbs on Drug Approval Jul 20 2016
Sarepta Therapeutics reports 2Q loss Jul 19 2016
Sarepta Therapeutics reports 2Q loss Jul 19 2016
SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 19 2016
Sarepta Therapeutics Announces Second Quarter 2016 Financial Results and Recent Corporate... Jul 19 2016
Sarepta Stock Slides As FDA Sends Another Bad Signal On DMD Jul 14 2016
Is There Hope for Sarepta? Jul 14 2016
Sarepta Therapeutics stock slumps 3.5% after other DMD drug is denied accelerated approval Jul 14 2016
Duchenne Drug Developer (Not Sarepta) Hit With Lengthy FDA Delay Jul 14 2016
Coverage Initiated on Select Biotech Equities Jul 12 2016
[$$] Where's the Drug, FDA? Jul 05 2016
Sarepta Stock Price Lifted by 'No Bad News Is Good News' Argument Jul 05 2016
[$$] Where’s the Drug, FDA? Jul 01 2016
SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 01 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK